Magnetic resonance imaging in patients with rheumatoid arthritis with complete remission treated with disease-modifying antirheumatic drugs or anti-tumour necrosis factor α agents [4]

Annals of the Rheumatic Diseases

Volumn 66, Issue 1, 2007, Pages 134-135

  Martinez Martinez M U ^a   Cuevas Orta, E ^a   Reyes Vaca, G ^a   Baranda, L ^a   Gonzalez Amaro R ^b   Abud Mendoza, C ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ARTHRITIS; BONE EROSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LETTER; MALE; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS; REMISSION; RHEUMATOID ARTHRITIS; SYNOVITIS; TREATMENT RESPONSE;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HAND; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REMISSION INDUCTION; SYNOVITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845990267     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.056432     Document Type: Letter

References (10)

1. Bathon JM, Martin RW, Fleischman RM, Tesser JR, Schiff MH, Keystone E, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000;343:1586-93.
2. Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. Infliximab (chimeric anti-tumor necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving methotrexate). A randomized phase III trial. Lancet 1999;354:1932- 9.
3. Pinals RS, Masi TA, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308- 15.
4. Gilkeson G, Polisson R, Sinclair H, Volgler J, Rice J, Caldwell D, et al. Early detection of carpal erosions in patients with rheumatoid arthritis: a pilot study of magnetic resonance imaging. J Rheumatol 1988;15:1361-6.
5. Ostergaard M, Hansen M, Stoltenberg M, Gideon P, Klarlund M, Jensen KE, et al. Magnetic resonance imaging determined synovial membrane volume as marker of disease activity and predictor of progressive joint destruction in the wrist of patients with rheumatoid arthritis. Arthritis Rheum 1999;42:918-29.
6. Savnik A, Malmskov H, Thomsen HS, Graff LB, Nielsen H, Danneskiold Samsoe B, et al. Magnetic resonance imaging of the wrist and finger joints in patients with inflammatory joint diseases. J Rheumatol 2001;28:2193-200.
7. Reece RJ, Kraan MC, Radjenovic A, Veale DJ, O'Connor PJ, Ridgway JP, et al. Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging. Arthritis Rheum 2002;46:366-72.
8. Eibjerg BJ, Vestergaard A, Jacobsen S, Thomsen S, Ostergaard M. The smallest detectable difference and sensitivity to change of magnetic resonance imaging and radiographic scoring of structural joint damage in rheumatoid arthritis finger, wrist, and toe joints: a comparison of the omeract rheumatoid arthritis magnetic resonance imaging score applied to different joint combinations and the Sharp/van der Heijde radiographic score. Arthritis Rheum 2005;52:2300-6.
9. Lee J, Lee SK, Suh JS, Yoon M, Song JH, Lee CH, et al. Magnetic resonance imaging of the wrist in defining remission of rheumatoid arthritis. J Rheumatol 1997;24:1303-8.
10. Zikou AK, Argyropoulou MI, Voulgari PV, Xydis VG, Nikas SN, Efremidis SC, et al. Magnetic resonance imaging of hand synovitis in patients with rheumatoid arthritis treated with adalimumab. J Rneumatol 2006;33:219-23.